Kelyniam Global Inc. to Present at the Life Sciences Virtual Investor Forum September 18th
Kelyniam Global (OTC:KLYG), a manufacturer of custom cranial implants, has announced that CFO Terrance Kurtenbach will present at the Life Sciences Virtual Investor Forum on September 18th, 2025, at 10:00 EDT.
The company will showcase its product portfolio, including the exclusively licensed CustomizedBone hydroxyapatite implant from Finceramica Spa and the OsteoStrip and Osteoplug product lines from Osteopore. Kelyniam aims to establish itself as a leader in regenerative options for U.S. surgeons.
Investors can participate in this interactive online event and schedule one-on-one meetings with management on September 18th (PM), 19th, and 22nd.
Kelyniam Global (OTC:KLYG), produttore di impianti cranici personalizzati, ha annunciato che il CFO Terrance Kurtenbach parteciperà al Life Sciences Virtual Investor Forum il 18 settembre 2025, alle ore 10:00 EDT.
L'azienda presenterà il proprio portafoglio prodotti, includendo l'impianto in hydroxyapatite CustomizedBone concesso in licenza esclusiva da Finceramica Spa e le linee di prodotti OsteoStrip e Osteoplug di Osteopore. Kelyniam mira a consolidarsi come leader nelle opzioni rigenerative per i chirurghi statunitensi. Gli investitori possono partecipare a questo evento online interattivo e fissare incontri individuali con il management il 18 settembre (pomeriggio), 19 e 22 settembre.
Kelyniam Global (OTC:KLYG), fabricante de implantes craneales personalizados, ha anunciado que el director financiero Terrance Kurtenbach presentará en el Life Sciences Virtual Investor Forum el 18 de septiembre de 2025 a las 10:00 EDT. La empresa mostrará su cartera de productos, incluida la implante de hidroxiapatita CustomizedBone con licencia exclusiva de Finceramica Spa y las líneas de productos OsteoStrip y Osteoplug de Osteopore. Kelyniam tiene como objetivo posicionarse como líder en opciones regenerativas para cirujanos en EE. UU. Los inversionistas pueden participar en este evento en línea interactivo y programar reuniones 1-a-1 con la dirección los días 18 (tarde), 19 y 22 de septiembre.
Kelyniam Global (OTC:KLYG), 맞춤 두개골 임플란트를 제조하는 회사가 재무 담당 부사장 Terrance Kurtenbach가 2025년 9월 18일 동부표준시 10:00에 열리는 Life Sciences Virtual Investor Forum에 발표할 것이라고 발표했습니다. 이 회사는 라이선스 독점으로 보유한 CustomizedBone 수화 하이드록시아파타이트 임플란트와 Osteopore의 OsteoStrip 및 Osteoplug 제품 라인을 포함한 포트폴리오를 선보일 예정입니다. Kelyniam은 미국 외과의사들을 위한 재생 옵션의 선두주자로 자리매김하는 것을 목표로 합니다. 투자자는 이 인터랙티브한 온라인 이벤트에 참여하고 9월 18일(오후), 19일, 22일에 경영진과의 1:1 미팅을 예약할 수 있습니다.
Kelyniam Global (OTC:KLYG), fabricant d’implants crâniens personnalisés, a annoncé que le directeur financier Terrance Kurtenbach participera au Life Sciences Virtual Investor Forum le 18 septembre 2025, à 10h00 EDT. L’entreprise présentera son portefeuille de produits, y compris l’implant en hydroxyapatite CustomizedBone sous licence exclusive de Finceramica Spa et les gammes de produits OsteoStrip et Osteoplug d’Osteopore. Kelyniam vise à se positionner comme leader des options régénératives pour les chirurgiens américains. Les investisseurs peuvent participer à cet événement en ligne interactif et programmer des réunions individuelles avec la direction les 18 septembre (après-midi), 19 et 22 septembre.
Kelyniam Global (OTC:KLYG), Hersteller maßgeschneiderter Schädelimplantate, hat bekannt gegeben, dass CFO Terrance Kurtenbach beim Life Sciences Virtual Investor Forum am 18. September 2025, um 10:00 EDT auftreten wird. Das Unternehmen wird sein Produktportfolio präsentieren, einschließlich des exklusiv lizenzierten CustomizedBone-Hydroxylapatit-Implant von Finceramica Spa und der Produktlinien OsteoStrip und Osteoplug von Osteopore. Kelyniam strebt danach, sich als führender Anbieter regenerativer Optionen für US-Chirurgen zu positionieren. Investoren können an dieser interaktiven Online-Veranstaltung teilnehmen und am 18. September (Nachmittag), 19. und 22. September Einzelgespräche mit dem Management vereinbaren.
شركة Kelyniam Global (OTC:KLYG)، المصنّعة لزرعات جمجمة مخصصة، أعلنت أن المدير المالي Terrance Kurtenbach سيقدّم في منتدى المستثمرين الافتراضي لعلوم الحياة في 18 سبتمبر 2025، الساعة 10:00 صباحاً بتوقيت EDT. ستعرض الشركة محفظة منتجاتها، بما في ذلك زرعات الهيدروكسي أباتيت CustomizedBone حصرية الترخيص من Finceramica Spa وخطوط منتجات OsteoStrip وOsteoplug من Osteopore. تهدف Kelyniam إلى ترسيخ مكانة كقائد في خيارات التجدد لجرّاحي الولايات المتحدة. يمكن للمستثمرين المشاركة في هذا الحدث التفاعلي عبر الإنترنت وترتيب لقاءات فردية مع الإدارة في 18 سبتمبر (بعد الظهر)، و19 و22 سبتمبر.
Kelyniam Global（OTC:KLYG），一家定制颅骨植入物制造商，宣布首席财务官 Terrance Kurtenbach 将在 2025年9月18日美国东部夏令时10:00 参加生命科学虚拟投资者论坛并进行演讲。公司将展示其产品组合，包括由 Finceramica Spa 独家许可的 CustomizedBone 水合羟基apatite 植入物，以及 Osteopore 的 OsteoStrip 和 Osteoplug 产品线。Kelyniam 旨在确立自己在为美国外科医生提供再生选项方面的领导地位。投资者可以参与此互动式在线活动，并在9月18日（下午）、9月19日和9月22日与管理层安排一对一会议。
- None.
- None.
The Company invites individual and institutional investors, as well as advisors and analysts, to attend online at VirtualInvestorConferences.com
DATE: September 18th
TIME: 10:00 EDT
LINK: Event Details
Company management will be available for 1x1 meetings: September 18 (PM), 19, 22. Please use the link above for scheduling.
This will be a live, interactive online event where investors are invited to ask the company questions in real-time. If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available after the event.
It is recommended that online investors pre-register and run the online system check to expedite participation and receive event updates.
Learn more about the event at www.virtualinvestorconferences.com.
Kelyniam has both sales momentum and additional product line enhancements to present to the current market. Surgeons who like the osteointegrative benefits of implants can find similar or better results with the CustomizedBone (hydroxyapatite) implant Kelyniam licensed exclusively from Finceramica Spa of Italy. Together with the OsteoStrip and Osteoplug product lines from Osteopore,
About Kelyniam
Kelyniam Inc., specializes in the rapid production of custom prosthetics utilizing computer aided design and computer aided manufacturing of advanced medical grade polymers. The Company develops, manufactures, and distributes custom cranial implants for patients. Kelyniam works directly with surgeons, health systems and payors to improve clinical and cost-of-care outcomes. Kelyniam's web site address is www.Kelyniam.com.
As a cautionary note to investors, certain matters discussed in this press release are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such matters involve risks and uncertainties that may cause actual results to differ materially, including the following: changes in economic conditions; general competitive factors; the Company's ability to execute its service and product sales plans; changes in the status of ability to market products; and the risks described from time to time in the Company's SEC reports
About Virtual Investor Conferences®
Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.
Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.
View original content:https://www.prnewswire.com/news-releases/kelyniam-global-inc-to-present-at-the-life-sciences-virtual-investor-forum-september-18th-302555870.html
SOURCE Kelyniam Global Inc
FAQ
When is Kelyniam Global (KLYG) presenting at the Life Sciences Virtual Investor Forum?
Who will be presenting for Kelyniam Global (KLYG) at the Virtual Investor Forum?
What products will Kelyniam Global (KLYG) discuss at the presentation?
How can investors participate in Kelyniam Global's (KLYG) presentation?
What does Kelyniam Global (KLYG) specialize in?
